Sort
50,496 grants matching “lung cancer”
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome
$1,145,460Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
$1,145,283Mariana C Stern · University Of Southern California · U54 · FY2023 · CA
Tumor-Stroma Interacions in the Tumor Microenvironment
$1,145,130Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2008 · CA
Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine
$1,144,955Andrea Califano · Columbia University Health Sciences · U01 · FY2019 · CA
REGULATION, RELEASE AND ACTION OF VASOPRESSIN
$1,144,646University Of Colorado Denver · P01 · FY2000 · DK
NHGRI/DIR Genomics Core
$1,144,148Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2025 · HG
1/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership
$1,143,914Hala Madanat · San Diego State University · U54 · FY2024 · CA
Integrated analyses of genetics, epigenetics, and gene expression
$1,142,960Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2021 · CA
Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens
$1,142,038David S Perlin · Hackensack University Medical Center · R01 · FY2023 · AI
Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens
$1,142,038David S Perlin · Hackensack University Medical Center · R01 · FY2022 · AI
1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
$1,142,009Brian M. Rivers · Morehouse School Of Medicine · U54 · FY2022 · CA
DCTD Human Toxicology and Pharmacology
$1,141,659David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
$1,140,720Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2023 · CA
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
$1,140,720Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2022 · CA
Biological mechanisms involved with PDT in the treatment of MPM
$1,140,490Theresa M Busch · University Of Pennsylvania · P01 · FY2019 · CA
Base Title: PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint BiomarkersTask Order Title: Colorectal Cancer (CRC) Prevention by TPST-1495 in PIRC rat mod
$1,140,397Chinthalapally Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2023 · CA
Epigenetic and immunologic aspects of neuroendocrine cancers
$1,140,320Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Metabolic Studies of Mouse Models of Obesity and Diabetes
$1,140,208Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2011 · DK
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
$1,140,000Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2024 · CA
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
$1,140,000Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2025 · CA
Biological And Biochemical Characterization Of Sigma Receptors
$1,139,116Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2019 · DA
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
$1,138,913Matthew Reed · Nob Hill Therapeutics, Inc. · R44 · FY2025 · CA
Center for Molecular, Cellular, and Translational Immunology
$1,138,534William R Green · Dartmouth College · P30 · FY2013 · GM
TGF-betas in breast cancer progression
$1,138,499Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$1,138,422Paul Kvale · Henry Ford Health System · N01 · FY2009 · CA